Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1874 1754 "

Sökning: L773:1874 1754

Sortera/gruppera träfflistan
  • Milovanovic, Micha, 1966-, et al. (författare)
  • Letter: Atrial fibrillation and platelet reactivity : in International Journal of Cardiology(ISSN 0167-5273)(EISSN 1874-1754)
  • 2010
  • Ingår i: International Journal of Cardiology. - Ireland : Elsevier. - 0167-5273 .- 1874-1754. ; 145:2, s. 357-358
  • Tidskriftsartikel (övrigt vetenskapligt)abstract
    • BACKGROUND: The impact of atrial fibrillation (AF) upon platelet reactivity has not been investigated. METHODS: Subjects were 33 individuals with AF who consented to elective electrical cardioversion (ECV) immediately before ECV determination of surface-bound fibrinogen after stimulation i.e. platelet reactivity was carried out. A flow cytometer was employed. ADP (1.7 and 8.5mumol/L) and a thrombin receptor activating peptide (54 and 74mumol/L) were used as agonists. The analyses were repeated after 26+/-8(SD) months. RESULTS: Compared to day 1 subjects with AF (n=18) had a trend towards lower platelet reactivity at study end. It reached significance when using 1.7mumol/L ADP. In contrast, after 26+/-8(SD) months sinus rhythm (SR) (n=15) was associated with significant lower reactivity with all agonists. CONCLUSION: After 26+/-8(SD) months patients returning with AF had higher platelet reactivity than those who remained with SR.
  • Adielsson, Anna, et al. (författare)
  • A 20-year perspective of in hospital cardiac arrest : Experiences from a university hospital with focus on wards with and without monitoring facilities.
  • 2016
  • Ingår i: International Journal of Cardiology. - 0167-5273 .- 1874-1754. ; 216, s. 194-199
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Knowledge about change in the characteristics and outcome of in hospital cardiac arrests (IHCAs) is insufficient.AIM: To describe a 20year perspective of in hospital cardiac arrest (IHCA) in wards with and without monitoring capabilities.SETTINGS: Sahlgrenska University Hospital (800 beds). The number of beds varied during the time of survey from 850-746 TIME: 1994-2013.METHODS: Retrospective registry study. Patients were assessed in four fiveyear intervals.INCLUSION CRITERIA: Witnessed and nonwitnessed IHCAs when cardiopulmonary resuscitation (CPR) was attempted.EXCLUSION CRITERIA: Age below 18years.RESULTS: In all, there were 2340 patients with IHCA during the time of the survey. 30-Day survival increased significantly in wards with monitoring facilities from 43.5% to 55.6% (p=0.002) for trend but not in wards without such facilities (p=0.003 for interaction between wards with/without monitoring facilities and time period). The CPC-score among survivors did not change significantly in any of the two types of wards. In wards with monitoring facilities there was a significant reduction of the delay time from collapse to start of CPR and an increase in the proportion of patients who were defibrillated before the arrival of the rescue team. In wards without such facilities there was a significant reduction of the delay from collapse to defibrillation. However, the latter observation corresponds to a marked decrease in the proportion of patients found in ventricular fibrillation.CONCLUSION: In a 20year perspective the treatment of in hospital cardiac arrest was characterised by a more rapid start of treatment. This was reflected in a significant increase in 30-day survival in wards with monitoring facilities. In wards without such facilities there was a decrease in patients found in ventricular fibrillation.
  • Agewall, S, et al. (författare)
  • Cardiovascular pharmacotherapy
  • 2016
  • Ingår i: International journal of cardiology. - 1874-1754. ; 224, s. 412-415
  • Tidskriftsartikel (refereegranskat)
  • Agewall, S, et al. (författare)
  • Sweet dreams might be bad
  • 2011
  • Ingår i: International journal of cardiology. - 1874-1754. ; 147:1, s. 139-140
  • Tidskriftsartikel (övrigt vetenskapligt)
  • Agewall, S (författare)
  • The large clinical statin trials
  • 2011
  • Ingår i: International journal of cardiology. - 1874-1754. ; 150:1, s. 108-111
  • Forskningsöversikt (refereegranskat)
  • Agvall, Björn, et al. (författare)
  • Resource use and cost implications of implementing a heart failure program for patients with systolic heart failure in Swedish primary health care
  • 2014
  • Ingår i: International Journal of Cardiology. - 0167-5273 .- 1874-1754. ; 176, s. 731-738
  • Tidskriftsartikel (refereegranskat)abstract
    • Aim: Heart failure (HF) is a common but serious condition which involves a significant economic burden on the health care economy. The purpose of this study was to evaluate cost and quality of life (QoL) implications of implementing a HF management program (HFMP) in primary health care (PHC).Methods and results: This was a prospective randomized open-label study including 160 patientswith a diagnosis of HF from five PHC centers in south-eastern Sweden. Patients randomized to the intervention group received information about HF from HF nurses and from a validated computer-based awareness program. HF nurses and physicians followed the patients intensely in order to optimize HF treatment according to current guidelines. The patients in the control group were followed by their regular general practitioner (GP) and received standard treatment according to local management routines. No significant changes were observed in NYHA class and quality-adjusted life years (QALY), implying that functional class and QoL were preserved. However, costs for hospital care (HC) and PHC were reduced by EUR 2167, or 33%. The total cost was EUR 4471 in the intervention group and EUR 6638 in the control group.Conclusions: Introducing HFMP in Swedish PHC in patients with HF entails a significant reduction in resource utilization and costs, and maintains QoL. Based on these results, a broader implementation of HFMP in PHC may be recommended. However, results should be confirmed with extended follow-up to verify  long-term effects.
  • Aimo, Alberto, et al. (författare)
  • High-sensitivity troponin T, NT-proBNP and glomerular filtration rate : A multimarker strategy for risk stratification in chronic heart failure
  • 2019
  • Ingår i: International Journal of Cardiology. - 0167-5273 .- 1874-1754. ; 277, s. 166-172
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: In a recent individual patient data meta-analysis, high-sensitivity troponin T (hs-TnT) emerged as robust predictor of prognosis in stable chronic heart failure (HF). In the same population, we compared the relative predictive performances of hs-TnT, N-terminal fraction of pro-B-type natriuretic peptide (NT-proBNP), hs-C-reactive protein (hs-CRP), and estimated glomerular filtration rate (eGFR) for prognosis.Methods and results: 9289 patients (66 ± 12 years, 77% men, 85% LVEF <40%, 60% ischemic HF) were evaluated over a 2.4-year median follow-up. Median eGFR was 58 mL/min/1.73 m2 (interquartile interval 46–70; n = 9220), hs-TnT 16 ng/L (8–20; n = 9289), NT-proBNP 1067 ng/L (433–2470; n = 8845), and hs-CRP 3.3 mg/L (1.4–7.8; n = 7083). In a model including all 3 biomarkers, only hs-TnT and NT-proBNP were independent predictors of all-cause and cardiovascular mortality and cardiovascular hospitalization. hs-TnT was a stronger predictor than NT-proBNP: for example, the risk for all-cause death increased by 54% per doubling of hs-TnT vs. 24% per doubling of NT-proBNP. eGFR showed independent prognostic value from both hs-TnT and NT-proBNP. The best hs-TnT and NT-proBNP cut-offs for the prediction of all-cause death increased progressively with declining renal function (eGFR ≥ 90: hs-TnT 13 ng/L and NT-proBNP 825 ng/L; eGFR < 30: hs-TnT 40 ng/L and NT-proBNP 4608 ng/L). Patient categorization according to these cut-offs effectively stratified patient prognosis across all eGFR classes.Conclusions: hs-TnT conveys independent prognostic information from NT-proBNP, while hs-CRP does not. Concomitant assessment of eGFR may further refine risk stratification. Patient classification according to hs-TnT and NT-proBNP cut-offs specific for the eGFR classes holds prognostic significance.
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (587)
forskningsöversikt (20)
konferensbidrag (2)
annan publikation (1)
Typ av innehåll
refereegranskat (518)
övrigt vetenskapligt (92)
Henein, Michael Y. (58)
Herlitz, Johan, 1949 (32)
Herlitz, Johan (30)
Karlsson, Thomas, 19 ... (24)
Omerovic, Elmir, 196 ... (22)
Henein, Michael (19)
visa fler...
Lindqvist, Per (18)
Agewall, S (18)
Redfors, Björn (18)
Fu, Michael, 1963 (16)
Johansson, Bengt (16)
Holzmann, MJ (15)
Hartford, Marianne, ... (14)
Lund, LH (13)
Moons, Philip, 1968 (13)
Dahlström, Ulf (13)
Caidahl, Kenneth, 19 ... (13)
Dellborg, Mikael, 19 ... (12)
Lund, Lars H. (12)
Savarese, G (12)
Nicoll, Rachel (12)
Shao, Yangzhen, 1981 (12)
Paneni, F. (11)
Sartipy, U (11)
Budts, Werner (11)
Mörner, Stellan (11)
Linde, C (10)
Jernberg, Tomas (10)
Janszky, I (9)
Thilén, Ulf (9)
Karlson, BW (9)
Wolk, Alicja (8)
Karlsson, T (8)
Bajraktari, Gani (8)
Li, Wei (8)
Carlsson, Axel C. (8)
Volpe, M (8)
Zhao, Ying (8)
Dellborg, Mikael (8)
Hjalmarson, Å (8)
Jaarsma, Tiny (7)
Svensson, L (7)
Alehagen, Urban (7)
Zannad, F (7)
Holmgren, Anders (7)
Larsson, Susanna C. (7)
Lagerqvist, Bo (7)
Wallentin, Lars (7)
Mondillo, Sergio (7)
Moons, Philip (7)
visa färre...
Karolinska Institutet (263)
Göteborgs universitet (145)
Umeå universitet (115)
Uppsala universitet (93)
Linköpings universitet (46)
Högskolan i Borås (43)
visa fler...
Lunds universitet (37)
Örebro universitet (21)
Stockholms universitet (10)
Kungliga Tekniska Högskolan (6)
Högskolan Väst (6)
Högskolan i Skövde (4)
Linnéuniversitetet (4)
Chalmers tekniska högskola (3)
Mälardalens universitet (1)
Jönköping University (1)
Mittuniversitetet (1)
Högskolan i Gävle (1)
visa färre...
Engelska (610)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (318)
Samhällsvetenskap (5)
Naturvetenskap (3)
Teknik (2)
Humaniora (1)


Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy